Skip to main content
Log in

Osteoarthritis, genetic and molecular mechanisms

  • Published:
Biogerontology Aims and scope Submit manuscript

Abstract

Osteoarthritis (OA) is the most common musculoskeletal disorder world-wide and has enormous social and economic consequences. OA is a multifactorial disorder in which ageing, genetic, hormonal and mechanical factors are all major contributors to its onset and progression. The primary lesion in OA would appear to occur in the articular cartilage (AC) which covers the weight-bearing surfaces of diarthrodial joints. Studies on AC have shown a decline in the chondrocyte numbers and their viability with ageing; largely due to nitric oxide radical mediated apoptosis. Since chondrocytes are responsible for the synthesis of the extensive extracellular matrix of AC, their decline in numbers limits the AC's ability to maintain homeostasis and thus functionality. Moreover, the chondrocytes remaining in the AC show diminished capacity to respond to growth factors which also restricts repair and their metabolism is greatly affected by cytokines and nitric oxide free radical produced during synovial inflammation and the imposition of supranormal mechanical stresses. Proteoglycans (PGs) provide the resilience of AC and a reduction in their synthesis, molecular size and increased catabolism in OA joints, marked lyimpairs AC capacity to efficiently respond to mechanical stress, leading to fibrillation and erosion down to subchondral bone. Recent OA research has sought to identify modalities which retard, or even reverse these pathological events. While many claims of disease modifying drugs in OA (DMOAD) have been made, our research has indicated that calcium pentosan polysulfate (CaPPS) exhibits considerable potential in this regard. CaPPS corrects many of the phenotypic imbalances (described above) in chondrocyte metabolism and promotes the synthesis of large PGs. Furthermore, it inhibits the enzymes responsible for PG and collagen degradation and increases the translation of tissue inhibitor of metalloproteinase-3 (TIMP-3) by synoviocytes and chondrocytes, thereby, reducing proteolytic and angiogenic activity within the joint space.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abbaszade I, Liu R-Q, Yang F, Rosenfeld SA, Ross OH, Link JR, Ellis DM, Tortorella MD, Pratta MA, Hollis JM, Wynn R, Duke JL, George HJ, Hillman (Jr) MC, Murphy K, Wiswall BH, Copeland RA, Decicco CP, Bruckner R, Nagase H, Itoh Y, Newton RC, Magolda RL, Trzaskos JM, Hollis FG, Arner EC and Burn TC (1999) Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274: 23443-23450

    Article  PubMed  CAS  Google Scholar 

  • Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A and Engler JA (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197-250

    PubMed  CAS  Google Scholar 

  • Byers PD, Maroudas A, Oztop F, Stockwell RA and Venn MF (1977) Histological and biochemical studies on cartilage from osteoarthrotic femoral heads with special reference to surface characteristics. Connect Tissue Res 5: 41-49

    PubMed  CAS  Google Scholar 

  • Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F and Collen D (1997) Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17: 439-444

    Article  PubMed  CAS  Google Scholar 

  • Doege KJ, Sasaki M, Kimura T and Yamada Y (1991) Complete coding sequence and deduced primary structure of the human cartilage large aggregating proteoglycan, aggrecan-human specific repeats, and additional alternatively spliced forms. Biol Chem 266: 894-902

    CAS  Google Scholar 

  • Evans CH, Watkins SC and Stafanovic-Racic M (1996) Nitric oxide and cartilage metabolism. Methods Enzymol 269: 75-88 Ghosh P (1999) The pathobiology of osteoarthritis and the rationale for the use of pentosan polysulfate for its treatment. Semin Arthritis Rheum 28: 211-267

    Google Scholar 

  • Iniguez MA, Pablos JL, Carreira PE, Cabr F and Gomez-Reino JJ (1998) Detection of COX-1 and COX-2 isoforms in synovial fluid cells from inflammatory joint diseases. Br J Rheumatol 37: 773-778

    Article  PubMed  CAS  Google Scholar 

  • Loeser RF, Shanker G, Carlson CS, Gardin JF, Shelton BJ and Sonntag WE (2000) Reduction in the chondrocyte response to insulin-like growth factor 1 in aging and osteoarthritis. Studies in a non-human primate model of naturally occurring disease. Arthritis Rheum 43: 2110-2120

    Article  PubMed  CAS  Google Scholar 

  • Mow VC, Ratcliffe A and Poole AR (1992) Cartilage and diarthrodial joints as paradigms for hierarchical materials and structures. Biomaterials 13: 67-97

    Article  PubMed  CAS  Google Scholar 

  • Munteanu SE, Ilic M-Z and Handley CJ (2000) Calcium pentosan polysulphate inhibits the catabolism of aggrecan in articular cartilage explant cultures. Arthritis Rheum 43: 2211-2218

    Article  PubMed  CAS  Google Scholar 

  • O'Hara BP, Urban J and Maroudas A (1990) Influence of cyclic loading on the nutrition of articular cartilage. Ann Rheum Dis 49: 536-539

    PubMed  Google Scholar 

  • Olney RC, Tsuchiya K, Wilson DM, Mohtai M, Maloney WJ, Schuman DJ and Smith RL (1996) Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding-protein-3 (IGFBP-3) and IGFbinding protein-5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab 81: 1096-1103

    Article  PubMed  CAS  Google Scholar 

  • Rogachefsky RA, Dean DD, Howell DS and Altman RD (1993) Treatment of canine osteoarthritis with insulin-like growth factor-1 (IGF-1) and sodium pentosan polysulfate. Osteoarthritis Cartilage 1: 105-114

    Article  PubMed  CAS  Google Scholar 

  • Sandy JD, Flannery CR, Neame PJ and Lohmander LS (1992) The structure of aggrecan fragments in human synovial fluid: Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain. J Clin Invest 89: 1512-1516

    Article  PubMed  CAS  Google Scholar 

  • Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hintz RL and Maroudas A (1995) Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritis synovial fluid and cartilage. Arch Biochem Biophys 324: 173-188

    Article  PubMed  CAS  Google Scholar 

  • Smith MD, Triantafillou S, Parker A, Youssef PP and Coleman M (1997) Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 24: 365-371

    PubMed  CAS  Google Scholar 

  • Studer RK, Levicoff E, Georgescu H, Miller L, Jaffurs D and Evans CH (2000) Nitric oxide inhibits chondrocyte response to IGF-1: inhibition of IGF-IR? tyrosine phosphorylation. Am J Physiol Cell Physiol 279: 961-969

    Google Scholar 

  • Takizawa M, Ohuchi E, Yamanaka H, Nakamura H, Ikeda E, Ghosh P and Okada Y (2000) Production of tissue inhibitor of metalloproteinases 3 is selectively enhanced by calcium pentosan polysulfate in human rheumatoid synovial fibroblasts. Arthritis Rheum 43: 812-820

    Article  PubMed  CAS  Google Scholar 

  • Tardif G, Reboul P, Pelletier J-P, Geng CS, Cloutier J-M and Martel-Pelletier J (1996) Normal expression of type I insulinlike growth factor receptor by human osteoarthritic chondrocytes with increased expression and synthesis of insulin-like growth factor binding proteins. Arthritis Rheum 39: 968-978

    PubMed  CAS  Google Scholar 

  • Tortorella MD, Burn TC, Pratta MA, Abbaszade I, Hollis JM, Liu R, Rosenfeld SA, Copeland RA, Decicco CP, Wynn R, Rockwell A, Yang F, Duke JL, Soloman K, George H, Bruckner R, Nagase H, Itoh Y, Ellis DM, Ross H, Wiswall BH, Burphy K, Hillman (Jr) MC, Hollis GF, Newton RC, Magolda RL, Trzaskos JM and Arner EC (1999) Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Sciences 284: 1664-1666

    CAS  Google Scholar 

  • Urban J, Maroudas A, Bayliss MT and Dillon J (1979) Swelling pressure of proteoglycans at the concentrations found in cartilaginous tissues. Biorheology 16: 447-464

    PubMed  CAS  Google Scholar 

  • Vincenti MP, White LA, Schroen DJ, Benbow U and Brinckerhoff CE (1996) Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription and mRNA stability. Crit Rev Eukaryot Gene Expr 6: 391-411

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter Ghosh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ghosh, P., Smith, M. Osteoarthritis, genetic and molecular mechanisms. Biogerontology 3, 85–88 (2002). https://doi.org/10.1023/A:1015219716583

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015219716583

Navigation